BioChemPartner.com - Your Best Biochemistry Lab Partner (Inhibitors, APIs, Intermediates)

TOP

Home
Products

Signaling Pathways

Research Areas

Intermediate

Nature products

Peptides

Impurities

Catalysts

Raw Materials
About Us
Service

Custom Synthesis

Technical Support

Bulk Quantity Discounts
Contact Us
中文

New Products

HDAC8-IN-1

Cat. NO.：BCP26192

CAS NO.：1417997-93-3
Fleroxacin

Cat. NO.：BCP28939

CAS NO.：79660-72-3
6-Methoxy-4-methylpuinoline

Cat. NO.：BCP28898

CAS NO.：41037-26-7
6-Chloro-4-methylpyridazin-3-amine

Cat. NO.：BCP28933

CAS NO.：64068-00-4
Methyl 4,6-dichloropyridazine-3-carboxylate

Cat. NO.：BCP28936

CAS NO.：372118-01-9
4-Acetyl-3-hydroxypyridine

Cat. NO.：BCP28934

CAS NO.：30152-05-7
6-Chloro-5-methylpyridazin-3-amine

Cat. NO.：BCP28935

CAS NO.：66346-87-0
PXL51107

Cat. NO.：BCP28928

CAS NO.：1627929-55-8
Nidufexor

Cat. NO.：BCP28929

CAS NO.：1773489-72-7
Cirsiliol

Cat. NO.：BCP28925

CAS NO.：34334-69-5

Custom Synthesis

Contact us for technical support. BioChemPartner is able to provide a comprehensive QC data package which maybe includes newest COA, HPLC,LC-MS,NMR etc.
Technical Support

Contact us for technical support. BioChemPartner is able to provide a comprehensive QC data package which maybe includes newest COA, HPLC,LC-MS,NMR etc.
Bulk Quantity Discounts

Competitive discounts on bulk quantities. BioChemPartner could offer attractive discounts on bulk quantities as either individual item or multiple products.

Publications Citing Use ofBioChemPartnerProducts

Cell Death Dis. 2017 May 4;8(5):e2766.
Nat Commun. 2015; 6: 7360.
Nat Commun. 2015;6:7227.
Oncogene. 2011 Sep 29;30(39):4097-106.
ACS Biomater. Sci. Eng.2017; 3 (5):843–853
Acta Biomater. 2017 Apr 15;53:399-413.
Acta Biomater. 2017 Nov;63:150-162.
Acta Pharm Sinica B.2017 Sep.
Antimicrob Agents Chemother. 2014 Aug; 58(8).
Antimicrob Agents Chemother. 2017 Aug;61(9).
Antimicrob Agents Chemother. 2017 May;61(6).
Atherosclerosis. 2016 Apr;247:48-57.
Autophagy. 2015 Feb; 11(2): 355–372.
Biochem Biophys Res Commun. 2013 Jun;435(3).
Biochem Biophys Res Commun. 2013 May;434(4).
Biochem Biophys Res Commun.2013 Jun;435(3).
Biochem Biophys Res Commun.2014 Apr;447(1).
Biochem Biophys Res Commun.2018 Jan;495(1).
Biochem Pharmacol. 2014 Sep 15;91(2):217-30.
Biochim Biophys Acta. 2018 Jan;1864(1):226-237.
Bioconjugate Chem.2018 Jan 17
Biomacromolecules. 2018 Jan 19
Biomacromolecules. 2017 Jun 12;18(6).
Biomacromolecules. 2017 Jun 12;18(6).
Biomater Sci. 2015 Jul 1; 3(7): 1114–1123.
Biomaterials. 2016 Sep; 101: 108–120.
Biomaterials. 2014 Jan;35(1):550-66.
Biomed Pharmacother. 2015 Dec;76:65-72.
Biomed Pharmacother.2014 Apr;68(3):335-341
BioMed Res Int.2017
Bioorg Med Chem. 2015 Dec 15;23(24):7765-76.
Bioorg Med Chem. 2015 Oct 1;23(19):6477-85.
Bioorg Med Chem. 2014 Jul 15;22(14):3739-48.
Biosci Trends. 2013 Oct;7(5):237-44.
Br J Cancer. 2012 Feb 14;106(4):763–767.
Br J Cancer. 2011 Sep 6;105(6):807–813.
Br J Pharmacol. 2016 Aug; 173(15): 2352–2368.
Cancer Biol Ther. 2014 Jun 1; 15(6): 721–734.
Cancer Res. 2010 Dec 15;70(24):10402-10.
Cell Signal. 2012 Sep;24(9):1803-9.
Cell Signal.2012 Sep;24(9):1781-1789
Clin Cancer Res. 2015 Jan 1; 21(1): 166–174.
Clin Cancer Res. 2014 Nov 15; 20(22): 5686–5696.
Clin Cancer Res. 2012 Nov 15;18(22):6219-26.
Clin Cancer Res. 2011 Apr 15;17(8):2140-8.
Colloids Surf B Biointerfaces. 2016 May;141:83-92.
Cryst. Growth Des.2017;17 (11):5994–6005
Cryst. Growth Des. 2016;16 (11):6537–6546
Curr Eye Res. 2017 Apr;42(4):534-541.
Curr Mol Med. 2015;15(5):478-86.
Drug Des Devel Ther. 2017; 11: 3481–3489.
Drug Des Devel Ther. 2015; 9: 4613–4620.
Drug Metab Dispos. 2015 Nov;43(11):1751-9.
EBioMedicine. 2016 Jan; 3: 54–66.
Environ Sci Technol. 2013 Feb 5;47(3):1373-80.
Environ Toxicol Pharmacol. 2017 Jan;49:81-88.
Epigenetics Chromatin. 2017; 10: 24.
Exp Ther Med. 2017 Oct; 14(4): 3105–3111.
Exp Ther Med. 2013 Feb; 5(2): 433–437.
Expert Opin Pharmacother.2012;13(17):2533-2543
Expert Opin Ther Targets. 2012 Apr;16:S61-70.
Free Radic Res. 2016 Oct;50(10):1106-1115.
Int Immunopharmacol. 2014 Feb;18(2):213-6.
Int J Antimicrob Agents. 2015 Oct;46(4):381-8.
Int J Cancer.2012 December 1;131(11):2487–2498
Int J Mol Med. 2016 Sep;38(3):969-75.
Int J Nanomedicine. 2016; 11: 2329–2343.
Int J Nanomedicine. 2015; 10: 6185–6198.
Int J Neuropsychopharmacol. 2015 Jun; pyv006.
Int J Oncol. 2017 Oct 16.
Int J Pharm. 2015 Nov 10;495(1):265-75.
J Asian Nat Prod Res. 2017 Oct 15:1-10.
J Biomed Nanotechnol.2016 Jul,12(7): 1463-1477.
J Control Release. 2017 Sep 10;261:126-137
J Control Release. 2016 Nov 10;241:68-80.
J Ethnopharmacol. 2015 Mar 13;162:369-76.
J Exp Bot.2015 Sep; 66(19): 5713–5725
J Med Chem. 2012 Jun 28;55(12):5784-96.
J Pharm Biomed Anal. 2016 Sep 10; 129: 473–481.
J Pharm Pharmacol. 2015 Oct;67(10):1393-405.
J Pharmacol Toxicol Methods. 2017 Mar - Apr.
J Proteome Res. 2013 Jul 5;12(7):3104-16.
Lett Drug Des Discov.2014 Nov;11(9):1090-1095(6).
Lett Drug Des Discov.2014 Jul;11(6):731-735(5).
mBio. 2014 Jul-Aug; 5(4): e01275-14.
Med Sci Monit. 2017; 23: 801–808.
Microb Pathog. 2017 Jan;102:36-41.
Mol Biosyst. 2012 Oct 30;8(12):3185-96.
Mol Cancer Ther. 2017 Oct;16(10):2130-2143.
Mol Cancer Ther. 2014 Jun;13(6):1589-98.
Mol Cancer Ther. 2012 Jul;11(7):1557-64.
Mol Med Rep. 2017 Jul; 16(1): 192–200.
Mol Oncol. 2017 Oct; 11(10): 1430–1447.
Mol Oncol. 2017 Aug; 11(8): 1065–1077.
Mol Pharmacol. 2012 Nov;82(5):958-71.
Nanomedicine (Lond). 2017 Apr;12(8):911-925.
Nanoscale. 2015;7(20):9298-310.
Nanoscale. 2014 Mar 21;6(6):3231-42.
Nat Med. 2013 Nov; 19(11): 1518–1523.
Oncol Lett. 2016 Jul; 12(1): 387–392.
Oncol Rep. 2016 Jun;35(6):3460-70.
Oncol Rep. 2014 Aug;32(2):716-22.
Oncotarget. 2016 Oct 11; 7(41): 67071–67086.
Oncotarget. 2016 Jun 14; 7(24): 36767–36782.
Oncotarget. 2016 May 3; 7(18): 25224–25240.
Oncotarget. 2016 Mar 1; 7(9): 9876–9889.
PLoS One. 2017; 12(9): e0185088.
PLoS One. 2017; 12(7): e0182019.
PLoS One. 2017; 12(6): e0178168.
PLoS One. 2016; 11(3): e0150567.
PLoS One. 2015; 10(7): e0134051.
PLoS One. 2014; 9(2): e89080.
PLoS One. 2014; 9(10): e109198.
PLoS One. 2012; 7(12): e52483.
Powder Diffraction.2015 Sep;30(3):298-299
Protein Cell. 2017 Apr; 8(4): 273–283.
Pulm Pharmacol Ther. 2016 Jun;38:1-9.
Redox Biol. 2017 Apr; 11: 524–534.
RSC Adv. 2018, 8, 444-453
Sci Rep. 2017; 7: 5519.
Sci Rep. 2017; 7: 12953.
Sci Rep. 2017; 7: 10393.
Sci Rep. 2016; 6: 25806.
Toxicol Appl Pharmacol. 2016 Nov 15;311:88-98.
Toxicology. 2014 Apr 6;318:22-31.
Tumour Biol. 2016 Jun;37(6):7305-14.
Tumour Biol. 2016 May;37(5):5951–5961
Tumour Biol. 2014 Oct;35(10):9759-67.
Ultrasound Med Biol. 2017 Nov;43(11):2651-2669.
United States Patent Application 20160324978
United States Patent Application 20150306112
United States Patent Application 20140323346
Virol J. 2017; 14: 55.
Virol J. 2017; 14: 2.
World J Gastroenterol. 2016 Apr 21; 22(15).

Products are for research use only. Not for human use. We do not sell to patients.

Terms&Conditions | Privacy Policy

Custom Synthesis

Technical Support

Bulk Quantity Discounts

Publications Citing Use ofBioChemPartnerProducts

About BioChemPartner

Customer Support

Ordering

Contact BioChemPartner